Hiscox Ltd HSX

Cybercrime is racing to catch up with artificial intelligence, and insurers are getting dragged into the fight. As attacks on AI models, cloud compute, and corporate data stack up, the companies that price and absorb cyber risk could face real pressure or fresh opportunity. This article unpacks 3 stocks exposed to that AI cyber threat story. It explains how this shift might affect their risk profiles and investor appeal. The stocks covered below are only a starter slice of the AI cyber...

Sanctions on Russian and Iranian energy are reshaping global trade routes, insurance needs and risk pricing, and that feeds directly into a niche corner of the market many investors overlook. Marine and specialty risk insurers sit close to these shifting flows, which can reshape premiums, claims and capital use. This article walks through 3 stocks exposed to this news and outlines how each might benefit or face new pressure so you can stress test your own watchlist. The three insurers...

NEW YORK, September 10, 2026--Elysian, the AI-powered claims quality platform for commercial insurance, today announced the appointment of Ian Thompson and Robin LaChapelle to their Strategic Advisory Board. Their perspectives will help shape Elysian’s strategy as it works to modernize the commercial claims experience for insurers and their policyholders. They join Bronek Masojada, Former Hiscox CEO, and current Chairman of the Board for Sirius Point, who was appointed as a strategic advisor in

LONDON, August 18, 2026--Advancing Analytics, a leading European data and AI consultancy that helps organisations turn complex data and AI challenges into measurable outcomes, today announced a growth investment from Databricks Ventures, the strategic investment arm of Databricks. The transaction makes Advancing Analytics the first UK-headquartered consulting firm to receive investment from Databricks Ventures. Tercera, a growth investor specialising in IT services companies, is also participati

This article first appeared on GuruFocus. Hiscox Ltd (HCXLY) has announced a total dividend of $0.34 per share, with the ex-dividend date set for August 17, 2026, and the payment date scheduled for October 6, 2026. This upcoming distribution includes a cash dividend of $0.34 per share, providing investors with a clear timeline to capture the next payout.

Price targets for Hiscox now cluster between 1,800 GBp and 2,050 GBp, with some analysts lifting their fair value estimates in step with updated models. The shift includes moves such as the top end rising to 2,050 GBp and a 1,960 GBp target attached to a more measured Add rating, reflecting a mix of confidence and caution on further upside. As you read on, you will see how this evolving analyst narrative might shape how you track Hiscox from here. Stay updated as the Fair Value for Hiscox...

LONDON, July 21, 2026 (GLOBE NEWSWIRE) -- Apollo, a Skyward Group company (Nasdaq: SKWD), the innovation inspired insurance platform, announces the appointment of David Burke as class lead to its product recall line, highlighting Apollo’s continued investment in underwriting talent and specialist expertise. Burke will lead the underwriting strategy for Apollo’s product recall offering, driving continued expansion of the business while broadening beyond its market leading automotive recall capabi

LONDON, June 30, 2026--Nolana AI was named runner-up at ILC ClaimsTech – The Pitch 2026, finishing second among 30 claims technology startups.

Price targets for Hiscox have been reset at the margin, with the current analyst fair value estimate nudged from £17.20 to £17.36, alongside a cluster of revised targets in the £18.00 to £19.60 range. Recent research, including higher targets and at least one rating downgrade to Add, frames this modest move as part of a broader reassessment of how much upside analysts see in the stock from here. Read on to see what these shifting targets could mean for your view on Hiscox and how to keep...

The latest analyst update for Hiscox comes with no change in the published price targets, keeping the existing figures in place for now. As you read on, you will see how to track future price target moves and interpret new commentary as it emerges so you can stay aligned with the evolving analyst narrative around the stock. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Hiscox. Do your thoughts align with the Bull or Bear...

Hiscox is back in focus after analysts lifted the fair value estimate from £16.06 to £16.90, with several external targets also resetting higher. Fresh research now clusters around upgraded levels such as £18.00, £17.10 and £16.11, compared with earlier anchors at £14.30 and £16.00, highlighting more optimistic pricing even where ratings stay Neutral. Read on to see how these shifting targets fit into the broader Hiscox story and what to watch as the narrative evolves. Analyst Price Targets...

CIBC Capital Markets on Wednesday said,, given recent media articles on the potential for Intact Fin

Hiscox (LON:HSX) reported first-quarter momentum across its portfolio, with Chief Financial Officer Paul Cooper highlighting double-digit group premium growth, a benign natural catastrophe quarter that helped offset early Middle East conflict exposure, and continued progress on the insurer’s change

FTSE 100 falls 161 points to 10,276 Markets await response from Iran to US peace proposal Shell, BAE Systems, JD Sport, Hiscox, Centrica, Helios, M&G report results 5.15pm: Stocks pull back London stocks came under pressure on Thursday, with the FTSE 100 down 161 points at...

Hiscox’s updated fair value estimate of £16.06, compared with the prior £16.35, sits alongside higher analyst price targets clustered around £16.11 and up to £17.10. Recent research suggests analysts are broadly aligned on how to think about valuation, even as they differ on how much upside those targets imply from the current share price. Keep reading to see how to interpret these moves and what to watch as the story around Hiscox continues to evolve. Stay updated as the Fair Value for...

Hiscox now carries an updated fair value estimate of £16.35, compared with £15.93 previously. This puts the focus squarely on how that refreshed target compares with current expectations. Recent Street research clustering between £16.11 and £17.10 broadly aligns with this new level, with analysts weighing execution risks against the valuation range implied by their targets. As you read on, you will see how to interpret these shifting targets and keep track of the evolving narrative around...